Jump to content

Cancer Research Technology Limited (20250152729). IMMUNOTHERAPY FOR CANCER

From WikiPatents

IMMUNOTHERAPY FOR CANCER

Abstract: an antibody-drug conjugate (adc) comprising an anti-human sema4a humanised or human antibody, a linker and a cytotoxin.

IPC:

CPC: A61K47/6849,

Retrieved from "https://wikipatents.org/index.php?title=Cancer_Research_Technology_Limited_(20250152729)._IMMUNOTHERAPY_FOR_CANCER&oldid=568854"

Cookies help us deliver our services. By using our services, you agree to our use of cookies.